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ABSTRACT
Background: Recent studies have suggested that
microvascular and macrovascular diseases are
associated with coronary events.
Objective: To test the hypothesis that asymptomatic
coronary heart disease (CHD) may be present in many
patients with diabetes with vascular complications.
Design: From April 2009 to August 2010, the authors
conducted a cross-sectional study to assess the
prevalence of asymptomatic CHD among patients with
type 2 diabetes with vascular complications at
a national diabetes centre in Japan. Eligibility criteria
included patients with type 2 diabetes with no known
CHD and one or more of the following four criteria: (1)
proliferative diabetic retinopathy or after
photocoagulation; (2) estimated glomerular ﬁltration
rate <30 ml/min/1.73 m
2 or an estimated glomerular
ﬁltration rate <45 ml/min/1.73 m
2 plus albuminuria;
(3) peripheral arterial disease; and (4) cerebrovascular
disease. Each patient underwent a stress single-photon
emission computed tomography; patients with
myocardial perfusion abnormalities then underwent
coronary angiography.
Results: A total of 1008 patients with type 2 diabetes
were screened, and 122 eligible patients consented to
participate. Stress single-photon emission computed
tomography revealed myocardial perfusion
abnormalities in 96 (79%) patients. Of the 112 patients
who completed the study protocol, 59 (53%) had
asymptomatic CHD with $50% diameter stenosis.
Additionally, 35 (31%) patients had multivessel
disease or left main disease, and 42 (38%) had
a coronary artery with $75% diameter stenosis. In the
multivariate logistic-regression analysis to identify
coronary risk factors associated with asymptomatic
CHD, the only signiﬁcant predictor was male sex (OR
6.18; 95% CI 2.30 to 16.64; p<0.001).
Conclusions: Asymptomatic CHD with $50%
diameter stenosis and myocardial perfusion
abnormalities was detected in more than half of the
patients with type 2 diabetes with vascular
complications.
INTRODUCTION
Diabetes is a risk factor of coronary heart
disease (CHD) which is a leading cause of
mortality.
1 Many studies have revealed that
some patients with diabetes may have
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ARTICLE SUMMARY
Article focus
- Many past studies have reported that some
patients with diabetes have asymptomatic coro-
nary heart disease (CHD).
- No deﬁnite markers for effectively identifying the
presence of asymptomatic CHD in patients with
diabetes presently exist.
- In recent studies, microvascular and macro-
vascular diseases were associated with the
subsequent coronary events.
Key messages
- Asymptomatic CHD with $75% diameter
stenosis and myocardial perfusion abnormalities
was detected in around 40% of the patients with
type 2 diabetes with vascular complications.
- Traditional coronary risk factors might not be
effective in screening for asymptomatic CHD
among patients with type 2 diabetes.
Strengths and limitations of this study
- This study revealed that many patients with
type 2 diabetes with vascular complications
have asymptomatic CHD with severe multivessel
stenosis, as well as myocardial ischaemia
on stress single-photon emission computed
tomography.
- We demonstrate that patients with type 2
diabetes with advanced microvascular or macro-
vascular diseases had a far greater prevalence of
myocardial perfusion abnormalities and asymp-
tomatic CHDs, compared with previous data.
- This study was performed at a single centre and
was limited to a speciﬁc geographical area.
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Open Access Researchasymptomatic CHD, and a retrospective study and
a small randomised trial suggested a possible beneﬁt
from CHD screening.
23In a large randomised
controlled trial, however, routine screening for asymp-
tomatic CHD among patients with type 2 diabetes was of
no beneﬁt to the cardiac outcome.
4 In addition, tradi-
tional coronary risk factors such as hypertension and
dyslipidaemia were not associated with silent ischaemia
and asymptomatic CHD.
56Therefore, aggressive routine
screening for asymptomatic CHD among all patients
with diabetes with or without these risk factors is not
recommended at present. No deﬁnite markers for
effectively identifying the presence of asymptomatic
CHD in patients with diabetes presently exist, and
further investigations are needed.
In recent studies, microvascular and macrovascular
diseases were associated with the subsequent coronary
events. Diabetic retinopathy was associated with the
onset of CHD and cardiovascular disease.
7e10 Patients
with proliferative diabetic retinopathy (PDR) and after
photocoagulation had a particularly high risk of cardio-
vascular disease.
11 An independent association was also
observed between renal dysfunction and cardiovascular
events,
12e16 and the risk of cardiovascular disease was
increased when proteinuria developed.
17 18 Moreover,
many studies suggested that macrovascular diseases such
as peripheral arterial disease (PAD) and cerebrovascular
disease were strongly associated with CHD.
19e24
Thus, we hypothesised that asymptomatic CHD may be
present in many patients with type 2 diabetes with
vascular complications such as advanced diabetic reti-
nopathy, renal dysfunction, PAD or cerebrovascular
disease, although each complication is regarded as
aetiologically non-identical to others, especially between
micro- and macrovascular complications for which
hyperglycaemia and hypercholesterolaemia play an
important role, respectively.
10 24 The aim of this study
was to assess the prevalence of asymptomatic CHD
among patients with type 2 diabetes with vascular
complications and no known CHD.
METHODS
Study design and participants
From April 2009 to August 2010, we conducted a cross-
sectional study, and patients were enrolled at the
National Center for Global Health and Medicine in
Tokyo, Japan. The institutional review boards approved
this study, and all the patients provided their written
informed consent. Eligibility criteria included patients
with type 2 diabetes without suggestive symptoms of
CHD between the ages of 40 and 75 years. Additionally,
all the patients had one or more of the following four
criteria: (1) PDR or after photocoagulation; (2) renal
dysfunction; (3) PAD; and (4) cerebrovascular disease.
An ophthalmologist diagnosed the PDR or after photo-
coagulation. Renal dysfunction was deﬁned as an esti-
mated glomerular ﬁltration rate (GFR) of <30 ml/min/
1.73 m
2 or an estimated GFR of <45 ml/min/1.73 m
2
plus albuminuria, corresponding to $30 mg/day or
$30 mg/g of creatinine. The estimated GFR was calcu-
lated using the following formula,
25 as recommended by
the Japanese Society of Nephrology: estimated GFR (ml/
min/1.73 m
2)¼1943 Cre
 1.0943 Age
 0.287 (30.739 if
the patient is a woman). PAD was deﬁned as an
ankleebrachial index (ABI) <0.9, conﬁrmed peripheral
artery stenosis based on radiological images, or after
surgical treatment. Cerebrovascular disease was deﬁned
as stroke or transient ischaemic attack. The exclusion
criteria included (1) known CHD or suspected CHD; (2)
the presence of antibodies to glutamic acid decarbox-
ylase; (3) acute kidney injury; and (4) a very poor
prognosis and inappropriate conditions for testing. The
inclusion criteria and exclusion criteria were conﬁrmed
using clinical records, laboratory data, questionnaires
and questioning by the physician.
Diagnostic approach and evaluation of outcomes
Stress single-photon emission computed tomography
(SPECT) has a high negative predictive value to rule out
CHD and does not require the use of contrast medium.
To avoid unnecessary tests, we ﬁrst performed stress
SPECT in all the patients who met the study criteria;
patients who exhibited myocardial perfusion abnormal-
ities then underwent conventional coronary angiog-
raphy (CAG), 64-slice multidetector-row computed
tomography (MDCT) coronary angiography, or both
examinations. We referred to the conventional CAG
ﬁndings when the patients underwent both imaging
procedures. The left main coronary artery, the left
anterior descending coronary artery, the left circumﬂex
coronary artery and the right coronary artery were each
assessed using the American Heart Association classiﬁ-
cation.
26 We diagnosed asymptomatic CHD when
a coronary artery with $50% diameter stenosis was
conﬁrmed using CAG.
19 The primary end point of this
study was the prevalence of asymptomatic CHD among
patients with type 2 diabetes with vascular complications.
Stress SPECT
ECG-gated stress SPECT imaging was performed in all
the patients using a dual-headed g camera (E.cam;
Siemens, Munich, Germany). Patients underwent exer-
cise stress (n¼75) according to the Bruce protocol.
Exercise testing was terminated when the patients
achieved a heart rate of 85% or more of the predicted
maximal heart rate, a sufﬁcient blood pressure response
(such as a systolic blood pressure $250 mm Hg),
a feeling that further exercise was impossible or signiﬁ-
cant severe ischaemic changes on an ECG recording.
Patients who were unable to perform the exercise
(n¼47) underwent a pharmacological stress test
comprised of a 6 min adenosine infusion protocol, as
recommended by The Japanese Society of Nuclear
Cardiology. Technetium-99m tetrofosmin SPECT
imaging was performed using a 1-day protocol in 108
patients, and thallium-201 was used in 14 patients. Two
experienced doctors of nuclear cardiology
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Coronary heart disease in type 2 diabetic patients with vascular complicationsindependently evaluated the images without knowing
the details of the clinical information. We diagnosed
myocardial perfusion abnormalities when one or more
of the doctors pointed out the presence of abnormal
myocardial perfusion on the stress SPECT images. For
the image analysis, quantitative gated SPECT data were
also used. Prior to interpreting the images, the data were
reviewed for artefacts. A 20-segment model was used for
reference, and the images were comprehensively inter-
preted. Ischaemia was diagnosed when one or more of
the doctors pointed out a reversible defect. On the other
hand, a scar was diagnosed when the defect was not
reversible.
Conventional CAG
When patients had severe coronary calciﬁcations with
coronary artery calcium (CAC) scores $400 Agatston
units, an irregular heart rhythm, advanced renal
dysfunction or severe stenosis on MDCT coronary angi-
ography, we aggressively conducted conventional CAG to
assess the coronary arteries. Conventional CAG images
were interpreted by two experienced cardiologists
blinded to the detailed patient characteristics in a usual
clinical setting.
Sixty-four-slice MDCT
In the absence of contraindications, the patients who
had myocardial perfusion abnormalities underwent
MDCT tests to determine their CAC scores followed by
CAG. The imaging was performed using 64-slice MDCT
with a slice thickness of 0.5 mm (Aquilion64; Toshiba
Medical Systems, Otawara, Japan). If necessary and
tolerated, oral beta-blockers (metoprolol 40e100 mg)
were provided before the scan to achieve a heart rate
<60 beats/min. We performed a non-enhanced
prospective electrocardiographically gated scan to
measure the CAC scores, which were calculated using
the Agatston method.
27 The MDCT coronary angiog-
raphy was performed using 6430.5 mm collimation and
retrospective electrocardiographic gating. MDCT images
were interpreted by an experienced cardiologist in
cooperation with radiologists who were unaware of the
detailed clinical backgrounds in a usual clinical setting.
All the coronary arteries and side branches with
a luminal diameter $ 2.0 mm were assessed.
Other measurements
The rest and exercise stress ECG tests were assessed by
a trained cardiologist who had no knowledge of the
clinical ﬁndings of the patients. We diagnosed an
abnormality on the rest ECG ﬁndings if ST segment
abnormalities, T wave abnormalities, an abnormal Q
wave, or a complete left bundle branch block were
observed; ischaemia was diagnosed on an exercise stress
ECG if the exercise induced any ischaemic changes.
We measured the ABI to evaluate PAD and the
brachialeankle pulse wave velocity to assess the presence
of arteriosclerosis in the peripheral arteries (Form PWV/
ABI; Colin Company, Komaki, Japan).
28 The lowest ABI
and the highest brachialeankle pulse wave velocity for
the left and right sides were used in subsequent analyses.
To estimate cardiac function such as the ejection
fraction and the wall motion, we conducted an echo-
cardiography examination (Aplio 80; Toshiba Medical
Systems, Otawara, Japan). The examinations were
performed by a trained ultrasonographer and cardiolo-
gist who had no knowledge of the patients’ clinical
information. Doppler echocardiography was also
performed to assess the peak Doppler velocities of the
early (E) and late diastolic ﬂows (A), the deceleration
Figure 1 Flow chart of study
participants. CHD, coronary heart
disease.
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Coronary heart disease in type 2 diabetic patients with vascular complicationsTable 1 Characteristics of study population*
N
All Men Women
122 84 (69%) 38 (31%)
Age (years) 122 64.1 (8.3) 63.9 (8.3) 64.6 (8.5)
Weight (kg) 122 64.6 (12.4) 66.7 (12.1) 60.1 (12.2)
Body-mass index (kg/m
2)y 122 24.5 (4.0) 24.3 (3.7) 25.1 (4.5)
Waist (cm) 112 90.3 (11.2) 89.8 (10.7) 91.5 (12.5)
Smoking 122
Non 47 (39%) 16 (18%) 31 (82%)
Former 37 (30%) 34 (41%) 3 (8%)
Current 38 (31%) 34 (41%) 4 (10%)
History of cerebrovascular diseasez 122 46 (37%) 32 (38%) 14 (36%)
Duration of diabetes (years) 122 16.0 (10.2) 16.5 (9.8) 15.2 (11.1)
Age (years) at the time of diabetes
diagnosis
122 49.0 (12.2) 48.4 (11.8) 50.4 (13.1)
Any diabetic retinopathy 122 97 (79%) 67 (79%) 30 (79%)
Proliferative diabetic retinopathy
or after photocoagulation
122 76 (62%) 50 (59%) 26 (68%)
A1C (%) 122 7.7 (1.5) 7.8 (1.7) 7.5 (1.2)
Treatment for diabetes 122
Diet 7 (6%) 7 (8%) 0 (0%)
Oral agents 59 (48%) 37 (44%) 22 (58%)
Insulin 15 (12%) 13 (16%) 2 (5%)
Insulin+oral agentsx 41 (34%) 21 (32%) 14 (37%)
Hypertension{ 122 95 (77%) 66 (78%) 29 (76%)
Treatment
Angiotensin II receptor
blockers/angiotensin-converting
enzyme inhibitors
88 (72%) 61 (72%) 27 (71%)
Calcium-channel blockers 55 (45%) 37 (44%) 18 (47%)
Diuretics 16 (13%) 9 (10%) 7 (18%)
Others 4 (3%) 3 (3%) 1 (2%)
Dyslipidaemia** 122 90 (73%) 60 (71%) 30 (79%)
Total cholesterol (mg/dl) 192.7 (39.0) 194.7 (42.4) 188.3 (30.9)
LDL cholesterol (mg/dl) 115.6 (40.5) 119.6 (43.8) 106.5 (30.4)
HDL cholesterol (mg/dl) 52.4 (14.8) 51.1 (13.5) 55.3 (17.2)
Triglyceride (mg/dl) 143.3 (85.9) 142.7 (86.1) 144.6 (86.7)
LDL/HDL ratio 2.4 (1.1) 2.5 (1.1) 2.2 (0.9)
Treatment
Statin 47 (38%) 25 (29%) 22 (57%)
Others 9 (7%) 7 (8%) 2 (5%)
Use of aspirin 122 33 (27%) 23 (27%) 10 (26%)
Creatinine (mg/dl) 120 1.04 (0.60) 1.08 (0.60) 0.94 (0.60)
Estimated glomerular ﬁltration rate
(ml/min/1.73 m
2)
120 62.1 (22.0) 63.3 (20.4) 59.7 (25.4)
<45 28 (23%) 17 (20%) 11 (28%)
<30 10 (8%) 5 (6%) 5 (13%)
Use of haemodialysis 2 2 (1%) 2 (2%) 0 (0%)
Albuminuria (mg/day or mg/g
of creatinine)
117
<30 32 (27%) 16 (20%) 16 (45%)
30e299 40 (34%) 28 (34%) 12 (33%)
$300 45 (39%) 37 (46%) 8 (22%)
Renal dysfunctionyy 122 25 (20%) 17 (20%) 8 (21%)
Brain natriuretic peptide (pg/ml) 113 37.2 (26.1 to 48.2) 19.4 (7.5 to 47.5) 24.8 (11 to 39.8)
Rest ECG
Any abnormal ﬁndings 122 27 (22%) 19 (22%) 8 (21%)
Abnormal Q wave changes 3 (2%) 2 (2%) 1 (2%)
Ischaemic ﬁndings on exercise stress ECG 64 25 (39%) 15 (36%) 10 (43%)
Cardiothoracic ratio on chest x-ray (%) 113 48.0 (4.4) 47.6 (4.5) 48.9 (4.0)
Continued
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Coronary heart disease in type 2 diabetic patients with vascular complicationstime (DT) and the E/A ratio for the mitral inﬂow.
Moreover, tissue Doppler imaging of the mitral annulus
was measured from the apical four-chamber view. A
sample volume was placed at the septal mitral annulus,
and the early (E9) diastolic velocity was measured. We
analysed the E/E9 ratio to assess the cardiac function.
29
The carotid intima-media thickness (IMT) was evalu-
ated using high-resolution B-mode ultrasound with
a 10 MHz linear transducer (Aplio XG; Toshiba Medical
Systems, Otawara, Japan).
30 A trained ultrasonographer
and a doctor or a skilled doctor alone who were unaware
of the patient’ characteristics assessed the maximum
carotid IMT. The maximum carotid IMT was deﬁned as
the thickest IMT for the left and right sides from the
common carotid artery to the internal carotid artery.
Statistical methods
Data are presented as the number (%), mean with SD,
and median with lower and upper ends of the IQR.
Continuous variables were compared using t tests and
Wilcoxon rank sum tests. Categorical variables were
compared using c
2 tests. A multivariate logistic-regres-
sion analysis of coronary risk factors, such as age, sex,
overweight or obesity, current smoking habit, hyperten-
sion and dyslipidaemia, was performed to identify coro-
nary risk factors associated with asymptomatic CHD.
p values <0.05 according to a two-sided test were
considered statistically signiﬁcant for all the tests. All
analyses were performed using Stata software, V.11.1.
RESULTS
A total of 1008 patients with type 2 diabetes between the
ages of 40 and 75 years were screened, and 219 met the
inclusion criteria for this study. Of the 206 eligible
patients without any exclusion criteria, 122 consented to
participate (ﬁgure 1). The clinical characteristics of this
study population are presented in table 1. The mean age
was 64.168.3 years, 84 (68%) were men, and the mean
A1C was 7.761.5%. The numbers of patients with PDR
or after photocoagulation, renal dysfunction, PAD and
cerebrovascular disease were 76 (62%), 25 (20%), 21
(17%) and 46 (37%), respectively.
Of the 122 patients, 96 (79%) had myocardial perfu-
sion abnormalities on stress SPECT: 70 (58%) had
ischaemia and 26 (21%) had a scar. Of the 96 patients
with myocardial perfusion abnormalities, 42 underwent
conventional CAG, 83 underwent MDCT coronary angi-
ography, and 39 underwent both examinations. Ten
patients did not undergo either MDCT coronary angi-
ography or CAG, and were excluded from the analysis to
determine the prevalence of asymptomatic CHD. Of the
112 patients who completed the study protocol, 59
Table 1 Continued
N
All Men Women
122 84 (69%) 38 (31%)
Ankleebrachial index 122 1.07 (0.17) 1.06 (0.18) 1.09 (0.17)
Brachialeankle pulse wave
velocity (cm/s)
108 2012.2 (377.3) 1940.5 (300.3) 2168.3 (474.8)
Peripheral arterial disease 122 21 (17%) 17 (20%) 4 (10%)
Echocardiographyzz
Ejection fraction (%) 108 67.3 (8.6) 66.4 (9.5) 69.4 (6.0)
Septal+posterior wall
thickness (mm)
108 21.2 (3.4) 21.3 (3.4) 20.9 (3.4)
>25 10 (9%) 6 (8%) 4 (11%)
E/A ratio 107 0.76 (0.21) 0.77 (0.17) 0.75 (0.28)
Deceleration time (ms) 107 236.4 (59.1) 232.6 (60.5) 244.6 (56.0)
E/E9 ratio 96 11.3 (3.4) 11.0 (2.86) 12.1 (4.35)
Abnormal wall motion 108 6 (5%) 6 (8%) 0 (0%)
Ultrasound of carotid artery 81
Maximum carotid intima-media
thickness (mm)
1.78 (1.07) 1.97 (1.13) 1.39 (0.86)
$1.1 53 (67%) 41 (77%) 12 (46%)
Coronary artery calcium scores
(Agatston units)
83 216.8 (52.0 to 602.7) 300.4 (65.6 to 1201.2) 110.9 (0 to 275.8)
To convert the values for cholesterol and triglycerides to millimoles per litre (mmol/l), multiply by 0.02586 and 0.01129, respectively.
*Data are number, number (%), mean (SD) or median (IQR).
yBody-mass index was calculated as the weight in kilograms divided by the square of height in metres.
zCerebrovascular disease was deﬁned as stroke or transient ischaemic attack.
xOral agents for the treatment of diabetes included metformin, sulfonylureas, thiazolidinediones, meglitinides and alpha-glucosidase inhibitors.
{Hypertension was deﬁned as a systolic blood pressure $140 mm Hg, diastolic blood pressure $90 mm Hg, or the use of antihypertensive
medication.
**Dyslipidaemia was deﬁned as low-density lipoprotein (LDL) $140 mg/dl, high-density lipoprotein (HDL) <40 mg/dl, or the use of lipid-lowering
drug.
yyRenal dysfunction was deﬁned as the estimated glomerular ﬁltration rate <30 ml/min/1.73 m
2 or the estimated glomerular ﬁltration rate
<45 ml/min/1.73 m
2 plus albuminuria, which was $30 mg/day or $30 mg/g of creatinine.
zzE/A ratio was the ratio of the peak Doppler velocities of early to late diastolic ﬂow in the mitral inﬂow. E/E9 ratio was the ratio of the peak
Doppler velocities of early in the mitral inﬂow to the early diastolic velocity at the septal mitral annulus.
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Coronary heart disease in type 2 diabetic patients with vascular complications(53%) had asymptomatic CHD (ﬁgure 2A). Thus, more
than half of the patients who met any one of the four
inclusion criteria for vascular complications had asymp-
tomatic CHD (ﬁgure 2B). The prevalences of asymp-
tomatic CHD among the patients who met only one
criteria and among the patients who met more than one
of the four inclusion criteria for vascular complications
were not signiﬁcantly different (p¼0.50). The preva-
lence of asymptomatic CHD in patients with myocardial
perfusion abnormalities on stress SPECT is shown in
ﬁgure 2C. The prevalences of asymptomatic CHD among
patients with ischaemia and among those with a scar
were not signiﬁcantly different. The CAC scores for the
patients with and for those without asymptomatic CHD
were signiﬁcantly different (ﬁgure 2D).
The majority of patients with asymptomatic CHD had
multivessel disease. Fifty-nine patients with asymptomatic
CHD had 1.860.8 vessels with $50% diameter stenosis:
24 (41%) patients had one-vessel disease, 22 (37%) had
two-vessel disease, and 13 (22%) had three-vessel disease
or left main disease. The maximum percentage diameter
stenosis in patients with asymptomatic CHD is also
assessed. Forty-two (71%) patients had $75% diameter
stenosis, and 24 (41%) had $90% diameter stenosis.
The analyses of the clinical variables among the patients
with and those without asymptomatic CHD are shown in
table 2. Men, a current smoking habit, age at the time of
diabetes diagnosis, the ejection fraction, the E/A ratio,
the maximum carotid IMT and the CAC scores differed
signiﬁcantly between the two groups in a univariate
analysis. However, abnormal ﬁndings on the rest ECG,
ischaemic ﬁndings on the exercise stress ECG and
abnormal wall motion on echocardiography were not
signiﬁcantly different. When a multivariate logistic-
regression analysis was performed to identify coronary
risk factors independently associated with asymptomatic
CHD, the only signiﬁcant predictor was male sex (OR
6.18; 95% CI 2.30 to 16.64; p<0.001). The result was
similar when the duration of diabetes was added to the
multivariate analysis.
DISCUSSION
This study reports that many patients with type 2 dia-
betes with vascular complications have asymptomatic
CHD with multivessel disease and severe stenosis in
addition to myocardial ischaemia on stress SPECT.
Moreover, asymptomatic CHD was detected in more
than half of the patients who met any one of the four
inclusion criteria for vascular complications. The asso-
ciation found between asymptomatic CHD and PAD in
Figure 2 Prevalence of myocardial perfusion abnormalities and asymptomatic coronary heart disease (CHD) (A). Prevalence of
asymptomatic CHD for each of the vascular complications (B). Prevalence of asymptomatic CHD in patients with ischaemia or scar
(C). Coronary artery calcium (CAC) scores in patients with or without asymptomatic CHD (D). PAD, peripheral arterial disease;
PDR, proliferative diabetic retinopathy.
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Coronary heart disease in type 2 diabetic patients with vascular complicationsTable 2 Analyses of clinical variables for asymptomatic coronary heart disease
Univariate analysis
Variable
Asymptomatic coronary
heart disease (+)
Asymptomatic coronary
heart disease (L) p Value
59 (53%) 53 (47%)
Men 51 (86%) 26 (49%) <0.001
Age (years) 62.4 (8.8) 65.3 (7.7) 0.07
Weight (kg) 65.3 (12.9) 64.7 (12.7) 0.79
Body-mass index (kg/m
2) 24.0 (3.4) 25.3 (4.6) 0.08
Waist (cm) 90.0 (11.4) 91.1 (11.9) 0.60
Current smoker 26 (44%) 10 (18%) 0.004
History of cerebrovascular disease 22 (37%) 21 (39%) 0.80
Duration of diabetes (years) 16.7 (10.5) 14.9 (10.0) 0.34
Age (years) at the time of diabetes diagnosis 46.7 (12.2) 51.4 (11.9) 0.04
Any diabetic retinopathy 46 (78%) 42 (79%) 0.86
Proliferative diabetic retinopathy or after photocoagulation 36 (61%) 34 (64%) 0.73
A1C (%) 7.3 (1.5) 7.4 (1.6) 0.76
Use of insulin 33 (55%) 21 (39%) 0.08
Hypertension 46 (78%) 40 (75%) 0.75
Dyslipidaemia 45 (76%) 39 (73%) 0.74
Total cholesterol (mg/dl) 192.8 (38.4) 196.0 (39.5) 0.67
Low-density lipoprotein cholesterol (mg/dl) 113.0 (36.6) 120.0 (38.5) 0.33
High-density lipoprotein cholesterol (mg/dl) 50.7 (13.7) 53.5 (15.7) 0.32
Triglyceride (mg/dl) 151.5 (89.0) 136.6 (82.3) 0.36
Low-density lipoprotein/high-density
lipoprotein ratio
2.4 (1.0) 2.4 (1.0) 0.85
Use of statin 21 (35%) 22 (41%) 0.52
Use of aspirin 16 (27%) 15 (28%) 0.88
Creatinine (mg/dl) 1.03 (0.60) 0.87 (0.35) 0.09
Glomerular ﬁltration rate (ml/min/1.73 m
2) 63.9 (20.7) 65.2 (20.0) 0.74
<45 13 (22%) 9 (17%) 0.50
<30 2 (3%) 3 (5%) 0.56
Albuminuria $30 (mg/day or mg/g of
creatinine)
43 (76%) 32 (62%) 0.11
Brain natriuretic peptide (pg/ml) 20.7 (7.6 to 35.4) 17.4 (9.5 to 42.9) 0.99
Rest ECG
Ischaemic ﬁndings on exercise stress ECG 12 (41%) 10 (35%) 0.66
Cardio thoracic ratio on chest x-ray (%) 47.3 (4.4) 48.8 (4.1) 0.08
Ankleebrachial index 1.06 (0.20) 1.06 (0.15) 0.98
Brachialeankle pulse wave velocity (cm/s) 1955.3 (306.4) 2067.4 (448.7) 0.14
Peripheral arterial disease 12 (22%) 8 (16%) 0.42
Echocardiography
Ejection fraction (%) 65.6 (9.1) 69.0 (8.0) 0.04
Septal wall+posterior wall thickness (mm) 20.8 (3.7) 21.2 (3.0) 0.55
E/A ratio 0.81 (0.16) 0.71 (0.24) 0.02
Deceleration time (ms) 225.7 (58.2) 247.5 (61.9) 0.07
E/E9 ratio 10.8 (3.3) 11.8 (3.2) 0.15
Abnormal wall motion 4 (7%) 2 (4%) 0.47
Ultrasound of carotid artery
Maximum carotid intima-media thickness (mm) 2.11 (1.30) 1.41 (0.70) 0.005
$1.1 28 (75%) 20 (55%) 0.07
Coronary artery calcium scores (Agatston units) 349.8 (99.6 to 1229.1) 133.2 (0.0 to 359.0) 0.003
Multivariate analysis
Variable OR (95% CI) p Value
Men 6.18 (2.30 to 16.64) <0.001
Age (years) 0.94 (0.89 to 1.00) 0.07
Body-mass index $25 0.49 (0.20 to 1.23) 0.13
Continued
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tion discovered in the previous study in which myocar-
dial scintigraphy and CAG were used to examine patients
with diabetes for the presence of silent coronary
stenosis.
20 Many past studies have reported that some
patients with diabetes have asymptomatic CHD.
However, the conditions under which the patients with
diabetes were most likely to have asymptomatic CHD was
unclear. We demonstrated that patients with type 2 dia-
betes with advanced microvascular or macrovascular
diseases had a far greater prevalence of myocardial
perfusion abnormalities and asymptomatic CHDs,
compared with previous data.
56Because the diabetic
complications had progressed, the patients might have
had severe autonomic denervation of the heart,
accounting for their asymptomatic presentation.
31 The
statistical analysis revealed that asymptomatic CHD was
more common among men than among women.
However, other coronary risk factors were not associated
with asymptomatic CHD. These results may be similar to
those of previous studies.
56Thus, traditional coronary
risk factors might not be effective in screening for
asymptomatic CHD among patients with type 2 diabetes.
We could not fully examine the CAC score (n¼83) and
the maximum IMT (n¼81) in 122 patients. However, the
results of the supplemental analyses showed that both
the CAC score and maximum carotid IMT were signiﬁ-
cant predictors when each factor was separately included
in the multivariate analysis (CAC scores and maximum
carotid IMT values for the analyses were available for 83
subjects and 75 subjects, respectively, and the p value was
0.034 and 0.036, respectively). Further research will be
required to identify possibly useful markers such as the
ejection fraction, E/A ratio, maximum carotid IMT and
CAC scores.
Importantly, some patients without signiﬁcant coro-
nary stenosis exhibited abnormal ﬁndings, such as
ischaemia on stress ECG, abnormal wall motion on
echocardiography or myocardial perfusion abnormali-
ties on stress SPECT. Although these facts might suggest
the possibility of false-positive results, coronary micro-
vascular dysfunction may be responsible for cardiac
disorders because the patients had many coronary
microvascular risk factors, such as diabetes, cigarette
smoking, dyslipidaemia and hypertension.
32 33 Further
investigation is needed for coronary microvascular
dysfunction.
Our study had several limitations. First, this study was
performed at a single centre and was limited to a speciﬁc
geographical area. Thus, large-scale studies at multiple
centres throughout the world will be necessary to conﬁrm
these results. However, we believe that this is an extremely
important study that may lead to numerous future trials
and that may have a large inﬂuence on diabetic
management. Second, we did not perform further tests in
patients with normal myocardial perfusion on stress
SPECT. Therefore, some patients with normal myocardial
perfusion might have had asymptomatic CHD. However,
stress SPECT has a very high sensitivity for CHD and
affects the decisions regarding future treatment.
34
Consequently, this diagnostic approach may enable
unnecessary angiography to be effectively avoided. Third,
the coronary arteries in some of the patients were eval-
uated using MDCTcoronary angiography alone. In large-
scale studies, a high rate of agreement between MDCT
coronary angiography and conventional CAG has been
conﬁrmed.
35 Furthermore, conventional CAG was
performed in most of the severe calciﬁcation cases with
CAC scores $400 Agatston units, which could be prob-
lematic for MDCT coronary angiography.
36 The median
CAC scores in the 44 patients who underwent MDCT
coronary angiography alone was 149.0 (14.1e383.4)
Agatston units. Thus, we assumed that the diagnosis of
CHD was accurate. Fourth, our approach based on image
information representing anatomical rather than func-
tional aspects possibly misses some of the ischaemic
changes of CHD, and this may explain the lack between
vasculopathy and asymptomatic CHD observed in our
current survey. Lastly, we had only 21 subjects with PAD,
and that may be because of the relatively low prevalence
of isolated PAD (eg, PAD without CHD) in the Japanese
population, and in fact a paper from Japan reported that
around half of the patients with PAD in their study also
had CHD.
37 The high mean PWV values possibly
reﬂected advanced arteriosclerosis of the subjects. In
addition, it should be mentioned that the renal function
did not worsen in any of the patients after CAG and
MDCT in this series of observations.
In conclusion, this study revealed that asymptomatic
CHD with myocardial perfusion abnormalities was
detected in more than half of the patients with type 2
diabetes with vascular complications. A relationship
between CHD and sudden cardiac death has been
revealed,
38 and we expect that the results of this study
Table 2 Continued
Multivariate analysis
Variable OR (95% CI) p Value
Current smoking 2.05 (0.75 to 5.54) 0.15
Hypertension 1.26 (0.45 to 3.50) 0.65
Dyslipidaemia 2.16 (0.77 to 6.05) 0.14
Data are number (%), mean (SD), median (IQR), OR, or 95% CI. To convert the values for cholesterol and triglycerides to millimoles per litre
(mmol/l), multiply by 0.02586 and 0.01129, respectively.
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and sudden cardiac death among patients with type 2
diabetes. However, the best approach to treating
asymptomatic CHD remains unknown. Therefore,
randomised controlled trials are needed to determine
the optimal management.
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